Bob Young

5.9k total citations · 3 hit papers
45 papers, 2.4k citations indexed

About

Bob Young is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Occupational Therapy. According to data from OpenAlex, Bob Young has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Epidemiology and 7 papers in Occupational Therapy. Recurrent topics in Bob Young's work include Diabetes Management and Education (14 papers), Chronic Disease Management Strategies (13 papers) and Diabetes Management and Research (13 papers). Bob Young is often cited by papers focused on Diabetes Management and Education (14 papers), Chronic Disease Management Strategies (13 papers) and Diabetes Management and Research (13 papers). Bob Young collaborates with scholars based in United Kingdom, Ireland and United States. Bob Young's co-authors include Emma Barron, Jonathan Valabhji, Naomi Holman, Kamlesh Khunti, Chirag Bakhai, Nicholas J. Wareham, Partha Kar, Naveed Sattar, Peter Knighton and Dominique Bradley and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Bob Young

43 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

2020 639 citations Emma Barron, Chirag Bakhai et al. The Lancet Diabetes & Endocrinology profile →
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

2020 600 citations Naomi Holman, Peter Knighton et al. The Lancet Diabetes & Endocrinology profile →
The cost of diabetic foot ulcers and amputations to the National Health Service in England

2019 271 citations Emma Barron, Paul Chadwick et al. Diabetic Medicine profile →

Peers

Countries citing papers authored by Bob Young

Since Specialization

Citations

This map shows the geographic impact of Bob Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Young more than expected).

Fields of papers citing papers by Bob Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Young. The network helps show where Bob Young may publish in the future.

Co-authorship network of co-authors of Bob Young

This figure shows the co-authorship network connecting the top 25 collaborators of Bob Young. A scholar is included among the top collaborators of Bob Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob Young. Bob Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019 2025 ·Diabetes Obesity and Metabolism ·Naomi Holman, Bob Young, Edward W. Gregg, Nicholas J. Wareham, Stephen J. Sharp, Kamlesh Khunti, Naveed Sattar, Jonathan Valabhji	0
2	Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management 2024 ·Diabetologia ·Naomi Holman, (unknown), Bob Young, Jonathan Valabhji, William Jeffcoate, Frances L. Game	7
3	Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England 2024 ·Diabetologia ·Jonathan Valabhji, Naomi Holman, Nicholas Collins, Bob Young, Paul Chadwick, (unknown), (unknown), Satyan Rajbhandari, (unknown), Marie‐France Kong, Simon Ashwell, (unknown), Sanjeev N. Mehta, Chris Manu, Michael Edmonds, Catherine Gooday, Ketan Dhatariya	1
4	Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019 2024 ·Diabetes Obesity and Metabolism ·Naomi Holman, Bob Young, Edward W. Gregg, Nicholas J. Wareham, Stephen J. Sharp, Kamlesh Khunti, Naveed Sattar, Jonathan Valabhji	3
5	Improving risk prediction model quality in the critically ill: data linkage study 2022 ·SHILAP Revista de lepidopterología ·Paloma Ferrando-Vivas, Manu Shankar‐Hari, Karen Thomas, James Doidge, Fergus Caskey, Lui G. Forni, Steve Harris, Marlies Ostermann, Ivan Gornik, Naomi Holman, Nazir Lone, Bob Young, David P. Jenkins, Stephen Webb, Jerry P. Nolan, Jasmeet Soar, Kathy Rowan, David A Harrison	1
6	Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit 2022 ·Diabetes Care ·Naomi Holman, Sarah H. Wild, Kamlesh Khunti, Peter Knighton, (unknown), Chirag Bakhai, Bob Young, Naveed Sattar, Jonathan Valabhji, Edward W. Gregg	32
7	Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study 2022 ·The Lancet Diabetes & Endocrinology ·Jonathan Valabhji, Emma Barron, Tessa Gorton, Chirag Bakhai, Partha Kar, Bob Young, Kamlesh Khunti, Naomi Holman, Naveed Sattar, Nicholas J. Wareham	32
8	Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England 2021 ·The Lancet Diabetes & Endocrinology ·Kamlesh Khunti, Peter Knighton, Francesco Zaccardi, Chirag Bakhai, Emma Barron, Naomi Holman, Partha Kar, (unknown), Naveed Sattar, Stephen J. Sharp, Nicholas J. Wareham, (unknown), (unknown), Bob Young, Jonathan Valabhji	123
9	Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study 2021 ·The Lancet Diabetes & Endocrinology ·Shivani Misra, Emma Barron, Eszter P. Vamos, Stephen R. Thomas, Ketan Dhatariya, Partha Kar, Bob Young, Kamlesh Khunti, Jonathan Valabhji	41
10	Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study breakdown → 2020 ·The Lancet Diabetes & Endocrinology ·Emma Barron, Chirag Bakhai, Partha Kar, (unknown), Dominique Bradley, Hassan Ismail, Peter Knighton, Naomi Holman, Kamlesh Khunti, Naveed Sattar, Nicholas J. Wareham, Bob Young, Jonathan Valabhji	639
11	Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study 2020 ·BMJ Open Diabetes Research & Care ·Emma Barron, Shivani Misra, Emma English, W. Garry John, Michael Sampson, Max Bachmann, Julian H. Barth, Nick Oliver, K. G. M. M. Alberti, Chirag Bakhai, Simon O’Neill, Bob Young, Nicholas J. Wareham, Kamlesh Khunti, Susan A. Jebb, Jenifer Smith, Jonathan Valabhji	9
12	Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study breakdown → 2020 ·The Lancet Diabetes & Endocrinology ·Naomi Holman, Peter Knighton, Partha Kar, (unknown), (unknown), (unknown), Emma Barron, Chirag Bakhai, Kamlesh Khunti, Nicholas J. Wareham, Naveed Sattar, Bob Young, Jonathan Valabhji	600
13	Driving Construction Health and Safety Through Procurement Strategy. 2019 ·Research Open (London South Bank University) ·Bob Young, (unknown), (unknown), Herbert Robinson, Obas John Ebohon	1
14	Using data to tackle the burden of amputation in diabetes 2017 ·The Lancet ·William Jeffcoate, Emma Barron, (unknown), Jonathan Valabhji, Bob Young	17
15	Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study 2017 ·Diabetologia ·Helen Murphy, Ruth Bell, Cher Cartwright, (unknown), Michael Maresh, Margery Morgan, (unknown), Bob Young, Nick Lewis‐Barned	150
16	Pilot study to assess measures to be used in the prospective audit of the management of foot ulcers in people with diabetes 2014 ·Diabetic Medicine ·Naomi Holman, Bob Young, (unknown), William Jeffcoate, (unknown)	19
17	Real time presence of a microbiologist in a multidisciplinary diabetes foot clinic 2012 ·Diabetes Research and Clinical Practice ·Angela Paisley, (unknown), Chinari Subudhi, Paul Chadwick, Paul Chadwick, Bob Young	7
18	Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits¹ 2011 ·Diabetic Medicine ·Naomi Holman, Nick Lewis‐Barned, Ruth Bell, (unknown), Jo Modder, Jason Gardosi, Anne Dornhorst, Rowan Hillson, Bob Young, Helen Murphy, (unknown)	19
19	The Diabetes National Service Framework – a real opportunity? 2004 ·Clinical Medicine ·Bob Young	2
20	Experience with the Rhys Hearn geriatric workload package--a regional survey. 1981 ·PubMed ·(unknown), Bob Young	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact